Argos Therapeutics Forecast and Stock Analysis
Technical ARGS stock analysis for Wednesday June 26, 2019.
Argos Therapeutics gained 47.72% in the last trading day ( Wednesday, 26th Jun 2019 ), rising from $0.05 to $0.07 During day the stock fluctuated 52.29% from a day low at $0.05 to a day high of $0.07. The price has been going up and down for this period, and there has been a 13.25% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 23 154 more shares were traded than the day before. In total, 24 580 shares bought and sold for approximately $1 670.21.
- 30 day high of the ARGS stock price was $0.08 and low was $0.04.
- 90 day high was $0.09 and low was $0.04.
- 52 week high for the Argos Therapeutics - $0.25 and low - $0.02.
Argos Therapeutics lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.07 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -21.66% during the next 3 months and, with 90% probability hold a price between $0.03 and $0.06 at the end of this period.
A buy signal was issued from a pivot bottom point on Tuesday June 25, 2019, which indicates further gains until a new top pivot has been found. Argos Therapeutics has rising volume and follows the last lift in the price. This considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Argos Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.07. On a fall, the stock will find some support from the short-term average at $0.07. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSI14 is 45 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $0.06 and $0.06.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Argos Therapeutics finds support just below today's level at $0.06. If this is broken, then the next support from accumulated volume will be at $0.06 and $0.06.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 52.29%. For the last week, the stock has had a daily average volatility of 46.61%.
Our recommended stoploss: $0.06 (-5.78%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)
46.61 %Average volatility
Very Low Low Medium High Very High
Argos Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ARGS $0.07 ($0.02 47.72%)|
ARGS is up $0.02 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ARGS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ARGS analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us